STEMINENT BIOTHERAPEUTICS, INC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.3 TWD | -3.04% |
|
-4.72% | 0.00% |
| 1 week | -4.72% | ||
| Current month | -9.55% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| 1 day | -3.04% | ||
| 1 week | -4.72% | ||
| Current month | -9.55% | ||
| 1 month | -8.87% |
1 week
30.15
31.95
1 month
29.4535.00
Current year
28.5553.00
1 year
28.5553.00
3 years
28.5553.00
5 years
28.5553.00
10 years
28.5553.00
Steminent Biotherapeutics Inc is a Taiwan-based trading company mainly engaged in the research and development of new stem cell drugs and the development of allogeneic mesenchymal stem cell technology platforms. The Company's main product is the new stem cell drug product Stemchymal. The new stem cell drug product Stemchymal is used to treat spinocerebellar ataxia, Huntington's disease, acute ischemic stroke, acute inflammatory indications and other diseases.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 52.61M | |
| +29.77% | 49.46B | |
| +1.00% | 42.58B | |
| +50.01% | 42.49B | |
| -5.26% | 29.09B | |
| +13.68% | 26.61B | |
| -22.99% | 18.64B | |
| +8.22% | 13.16B | |
| +32.41% | 12.55B | |
| +24.01% | 12.1B |
- Stock Market
- Equities
- 7729 Stock